3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
7
Fatigue
6
Prostatic Neoplasms
5
Lung Neoplasms
5
Motor Activity
4
Lymphedema
4
Hematologic Neoplasms
4
Pain
3
Trismus
2
Peripheral Nervous System Diseases
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioma
2
Esophageal Neoplasms
2
Cachexia
2
Breast Neoplasms, Male
2
Urologic Neoplasms
1
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Transcranial Magnetic Stimulation, Repetitive
1
Thrombosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Shoulder Pain
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Interventions
Amifampridine
4
thymoglobulin
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Walk Test
1
Prednisone
1
Physical Therapy Modalities
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Etoposide
1
Cytarabine
1
Carmustine
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lambert-Eaton Myasthenic Syndrome
×
Physical Therapy Modalities
×
Clear all
NCT07072676
2025-07-18
Risk of fall
LMU Klinikum
Phase NA
Enrolling by invitation
30 enrolled